Sionna Therapeutics, Inc.

NASDAQ:SION

Biotechnology

Healthcare
$2.97 +1.85%

+$0.68 today

Market cap
$134.35M
Beta
1.29
P/E (TTM)
-19.7
EPS (TTM)
-$1.90
52W Low $13.81High $48.45

Volume 0.52M

Average 0.39M

SION Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

No reported Net Margin figures are available to summarize.

Net Margin history

Percent of revenue · from the income statement

No Net Margin data reported for this period type.

Net Margin vs competitors

How SION compares with its peers on the latest reported figures

SION Competitors Peer median
Net Margin for SION and competitors
Company Period LTM level YoY 3-year change
ZYMEZymeworks Inc.LTM Sep 202616.3% +63.4 pp-106.7 pp
XERSXeris Biopharma Holdings, Inc.LTM Mar 20263.8% +24.1 pp+86.1 pp
ARDXArdelyx, Inc.LTM Mar 2026-13.6% +1.3 pp+113.7 pp
ABCLAbCellera Biologics Inc.LTM Sep 2026-218.5% +267.5 pp-227.5 pp
JANXJanux Therapeutics, Inc.LTM Mar 2026-529.7% +303.0 pp-404.0 pp
MAZEMaze Therapeutics, Inc.LTM Mar 2026-612.7% -643.7 pp—
IMNMImmunome, Inc.FY2025-3060.0% +180.4 pp—
CLDXCelldex Therapeutics, Inc.LTM Sep 2026-275986.6% -267350.8 pp-12487.7 pp
SIONSionna Therapeutics, Inc.FY2025— ——
BHVNBiohaven Ltd.FY2025— ——
VERAVera Therapeutics, Inc.FY2025— ——
Peer median (excluding SION) -374.1%+43.8 pp-167.1 pp

Competitors are the stored peer set for SION. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue0000
Cost of Revenue00668K647K
Gross Profit00(668K)(647K)
Gross Margin————
Research & Development34.61M40.63M57.29M60.26M
Selling, General & Admin6.77M9.71M13.27M28.72M
Operating Expenses41.37M50.33M69.89M88.34M
Depreciation & Amortization122K583K668K647K
EBITDA(40.12M)(46.68M)(61.02M)(74.62M)
EBITDA Margin————
Operating Income(41.37M)(50.33M)(70.56M)(88.98M)
Operating Margin————
Interest Income1.13M2.77M8.17M13.3M
Interest Expense0000
Other Income / Expenses1.13M3.07M8.87M13.71M
Income Before Tax(40.24M)(47.26M)(61.69M)(75.27M)
Pre-Tax Margin————
Income Tax Expense0000
Net Income(40.24M)(47.26M)(61.69M)(75.27M)
Net Margin————
EPS (Basic)(0.91)(1.07)(1.40)(1.88)
EPS (Diluted)(0.91)(1.07)(1.40)(1.88)
Weighted Avg Shares44.12M44.12M44.12M39.96M
Weighted Avg Shares (Diluted)44.12M44.12M44.12M39.96M

Sionna Therapeutics, Inc.

NASDAQ:SION

Intrinsic Alpha fair value

Locked

Current Price

$2.97

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.